Convalescent plasma for COVID-19: Promising, not proven.
Where this comes from
- Record sourced from PubMed, PMID 32759176.
- Also identified by DOI 10.3949/ccjm.87a.ccc056.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
While promising, convalescent plasma remains experimental and is not proven effective for COVID-19. In addition, many questions remain regarding the accuracy and predictive value of antibody testing of donors and patients, optimal donor selection, optimal timing, and selection of patients most likely to benefit. Until these questions are answered, convalescent plasma should ideally be used in the context of well-designed clinical trials.
Medical subject headings
- Betacoronavirus
- Clinical Laboratory Techniques
- Coronavirus Infections
- Pandemics
- Pneumonia, Viral
- Time-to-Treatment